Metraipolis › archive › dc_448c517258fb

Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage — Europe PMC PMID:41096183

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41096183
DOI
10.3390/jcm14197103
License (as archived)
solo-consultazione
Archived
2026-11-09T10:40:08.278Z
SHA-256 of the archived text
0aafe809ce6f8aae652d87464fbc9380e76d12e4dd1a309a6dc7dcc83af106c3
Stable URL of this page
https://metraipolis.com/documento/dc_448c517258fb

How to cite

Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage — Europe PMC PMID:41096183 — Europe PMC (en), https://europepmc.org/article/MED/41096183 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_448c517258fb (Metraipolis archive dc_448c517258fb, sha256 0aafe809ce6f8aae652d87464fbc9380e76d12e4dd1a309a6dc7dcc83af106c3)
BibTeX
@misc{dc448c517258fb,
  title = {Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage — Europe PMC PMID:41096183},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41096183},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_448c517258fb; sha256 0aafe809ce6f8aae652d87464fbc9380e76d12e4dd1a309a6dc7dcc83af106c3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41096183. Agents can read the archived copy with the MCP tool read_document.